Glenmark, Torrent Pharma sign deal co-market diabetes drug in India

Glenmark, Torrent Pharma sign deal to co-market diabetes drug in India

9:53 AM, 11th July 2019
Glenmark, Torrent Pharma sign deal to co-market diabetes drug in India

MUMBAI, INDIA: Glenmark Pharmaceuticals Ltd and Torrent Pharmaceuticals Limited have entered into a non-exclusive sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor, Remogliflozin Etabonate (Remogliflozin) in India.

Under the terms of the agreement, Glenmark will receive an upfront payment, license fees and royalties for the non-exclusive sub-license rights from Torrent. Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark ‘Zucator’ in India.

In April 2019, Glenmark received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials in which Remogliflozin demonstrated good efficacy and safety profile in a head-to-head comparison against Dapagliflozin.

Subsequently, Glenmark launched Remogliflozin indicated in the treatment of Type 2 Diabetes Mellitus in adults under the brand names ‘Remo’ and ‘Remozen’ while Torrent will commercialize Remogliflozin under the brand name ‘Zucator’. Moreover, Remogliflozin is available at a breakthrough price that is significantly lower and cost effective over other SGLT-2 inhibitors available in the country. Infact, Remogliflozin is the only SGLT2 inhibitor to be manufactured in India from active pharmaceutical ingredient (API) to formulation.

“We are pleased to partner and work closely with Torrent to provide access to innovative solutions for efficient diabetes management in India. The burden of diabetes in India is growing at an alarming rate and through this collaboration, we aim to improve access to the latest, novel and globally researched SGLT2 inhibitor by providing an effective, high quality and world-class treatment option to patients in India. This partnership will also lay the foundation for a long-term collaboration with Torrent for Remogliflozin in terms of its additional line extensions and further clinical development,” said Sujesh Vasudevan, President, India Formulations, Middle East and Africa at Glenmark Pharmaceuticals.

“We are pleased to collaborate with Glenmark for the novel anti-diabetic drug Remogliflozin. The drug will augment the Type 2 Diabetes Mellitus treatment armamentarium in the country and this partnership will be an important step towards enhancing access to the growing needs of diabetic patients,” added Dhruv Gulati, Executive Director (India & ROW), Torrent Pharma.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Westlake Chemicals rating outlook at stable: Fitch

NEW YORK, US: A report from Fitch Ratings Inc states that it has assigned a rating of 'BBB' rating to Westlake Chemical Corporation's €700 millio ...

Read more
Domo Chemicals renames nylon film business

LEUNA, GERMANY: Domo Chemicals underlines its position as one of the main providers of nylon film solutions in Europe by renaming its business current ...

Read more
Archroma to launch new range of high wet-fast disperse dyes

REINACH, SWITZERLAND: Archroma has launched its new Foron SP-WF, a range of high wet-fast disperse dyes for sportswear and active wear applicatio ...

Read more
K+S increases magnesium sulphate anhydrous capacity

KASSEL, GERMANY: K+S AG said that it will increase capacity for magnesium sulphate anhydrous, with the commissioning of a new facility at the Wintersh ...

Read more
Air Liquide to supply industrial gases to GCGV’s planned ethane cracker

HOUSTON, US: Air Liquide has signed a long-term agreement with Gulf Coast Growth Ventures (GCGV), to supply oxygen and nitrogen from its industrial ga ...

Read more
Nuberg EPC signs contract for chlor-alkali plant in Morocco

NEW DELHI, INDIA: Nuberg EPC has been selected by SCE Chemicals, Morocco as the EPC lump sum contractor to establish a new chlor-alkali plant. The pla ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X